After high-throughput screening, compound C3 came up as a potential candidate against influenza’s infections since its effect of increasing IFN levels was not affected by NS1, apparently because it activated a different pathway or because it acted downstream of NS1’s targets. The gene discussed is IFNA1; the disease is influenza.